Analysis of pathological role of RA Nurse-like cells in Joint destruction of RA
RA Nurse样细胞在RA关节破坏中的病理作用分析
基本信息
- 批准号:11470309
- 负责人:
- 金额:$ 10.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have established RA Nurse-Like Cell (RANC) characterized by pseudoemperipolesis from synovial tissues and bone marrow of patients with RA.RANC has various potential ; a nursing ability for lymphocytes from bone marrow and synovium of RA patients, production of hyaluronan etc, and was thought to play an pivotal role in pathomechanism of RA.In this study we investigated further effects of RANC in the pathogenesis of RA.1. We have cloned the novel gene specific for RANC ; NSR, #4-142. B lymphocyte cocultured with RANC is producing antibody, one of which is appeared to be anti elongation factor 1 alpha antibody.3. We have shown that mononuclear cells in RA synovial fluid could differentiate into osteoclast-like cell (OCL) which was positive for TRAP stain, have a ability of bone resorption and fulfils another osteoclastic characters. We have also established OCL from peripheral blood monocytes with support of RANC.4. In vivo analysis of RANC cocultured with mononuclear cells or B cells on articular cartilage showed severe degradation of cartilage but normal skin fibroblast caused almost no erosions.In conclusion, RANC may play an important role in both bone and cartilage destruction and contribute the pathomachanism of RA.
我们从RA患者的滑膜组织和骨髓中建立了以假胚泡形成为特征的RA护士样细胞(RANC),RANC具有多种潜能,如对RA患者骨髓和滑膜中淋巴细胞的护理能力、透明质酸的产生等,被认为在RA的发病机制中起着关键作用.我们已经克隆了RANC特异性的新基因; NSR,#4-142。与RANC共培养的B淋巴细胞正在产生抗体,其中一种似乎是抗延伸因子1 α抗体。3.我们发现RA滑液中的单个核细胞可分化为TRAP阳性的破骨细胞样细胞(OCL),具有骨吸收能力,并具有另一种骨细胞特性。我们还建立了OCL从外周血单核细胞的支持下,RANC。RANC与单核细胞或B细胞在关节软骨上共培养的体内分析显示,软骨严重降解,而正常皮肤成纤维细胞几乎没有引起侵蚀。结论:RANC可能在骨和软骨破坏中发挥重要作用,并参与RA的发病机制。
项目成果
期刊论文数量(80)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shi K,Ochi T.: "Foot Deformities in Rheumatoid Arthritis and Relevance of Disease Severity."J Rheumatol. 27. 84-9 (2000)
Shi K,Ochi T.:“类风湿性关节炎的足部畸形与疾病严重程度的相关性。”J Rheumatol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishimoto N, Tomita T, Ochi T, et al.: "IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor"Int Immunol. 12. 187-193 (2000)
Nishimoto N、Tomita T、Ochi T 等人:“在可溶性 IL-6 受体存在的情况下,IL-6 会抑制类风湿性关节炎患者的成纤维细胞滑膜细胞的增殖”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hirohata S, Tomita T, Ochi T, et al.: "Suppressive influences of methotrexate on the generation of CD14(+) monocyte-lineage cells from bone marrow of patients with rheumatoid arthritis"Clin Immunol. 91. 84-89 (1999)
Hirohata S、Tomita T、Ochi T 等人:“甲氨蝶呤对类风湿性关节炎患者骨髓中 CD14(+) 单核细胞谱系细胞生成的抑制作用”Clin Immunol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iijima T, Tomita T, Ochi T, et al.: "Incidence of postpartum onset disease among patients with rheumatoid arthritis"J Rheumatol. 26. 755-756 (1999)
Iijima T、Tomita T、Ochi T 等人:“类风湿性关节炎患者产后发病率”J Rheumatol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tomita T,Ochi T.: "Transcription Factor Decoy for NFkB Inhibits Cytokine and Adhesion Molecule Expressions in Synovial Cells Derived from Rheumatoid Arthritis. "Rheumarology. 39(7). 749-57 (2000)
Tomita T,Ochi T.:“NFkB 转录因子诱饵抑制类风湿性关节炎滑膜细胞中的细胞因子和粘附分子表达。”风湿病学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OCHI Takahiro其他文献
OCHI Takahiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OCHI Takahiro', 18)}}的其他基金
Involvement of bone marrow interstitial fibroblastic cells which support the differentiation of CD(+) peripheral-blood monocytes into TRAP positive cells. In bone and cartilage destruction in rheumatoid arthritis.
骨髓间质成纤维细胞的参与支持 CD(+) 外周血单核细胞分化为 TRAP 阳性细胞。
- 批准号:
13470311 - 财政年份:2001
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular analysis of interaction between hematopoietic cells and nurse cells established from patients with rheumatoid arthritis
类风湿性关节炎患者造血细胞和护理细胞之间相互作用的分子分析
- 批准号:
09470317 - 财政年份:1997
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of in vivo direct gene transfer system into joint using HVJ-liposome
HVJ-脂质体体内直接基因转移系统的建立
- 批准号:
07557098 - 财政年份:1995
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Abnormal Myeloid Lineage Cells Expressing the Difucosyl or Trifucosyl Type 2 Chain in Bone Marrow Cells of Patinets with Severe Rheumatoid Arthritis.
患有严重类风湿性关节炎的患者骨髓细胞中表达二岩藻糖基或三岩藻糖基 2 型链的异常骨髓谱系细胞。
- 批准号:
06454429 - 财政年份:1994
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
癌細胞特異糖鎖抗原による慢性関節リウマチ患者に対する感作療法
使用癌细胞特异性碳水化合物抗原对类风湿性关节炎患者进行敏化治疗
- 批准号:
04557066 - 财政年份:1992
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Development of Intradermal Sensitization Therapy to Ra Patients Using Oncofetal Carbohydrate Membrane Structure
利用癌胎碳水化合物膜结构开发 Ra 患者皮内致敏疗法
- 批准号:
01870065 - 财政年份:1992
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research
Serum Cytotoxic Factor and its' Inhibitorin Rheumatoid Arthritis.
血清细胞毒性因子及其抑制剂类风湿性关节炎。
- 批准号:
04807106 - 财政年份:1992
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Myeloid cell cascade bearing onco-fetal membrane structure found in the involved epiphyseal bone marrow in patients with severe active rheumatoid arthritis
在严重活动性类风湿关节炎患者受累骨骺骨髓中发现具有癌胎膜结构的骨髓细胞级联
- 批准号:
02454345 - 财政年份:1990
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)